Glimepiride

Glimepiride is an oral hypoglycemic (anti-diabetic drug) and is classified as a sulfonylurea. Glimepiride distinctly lower the blood glucose level by both defects of diabetes mellitus type 2, by stimulating pancreatic beta cells to produce more insulin and induced increased activity of peripheral insulin intra cellular receptor.

drukuj

Bioton WorldWide

Requires the Flash plugin. If the plugin is already installed, click here.

Members of the BIOTON Group

Struktura_1_widget

GPW

Contact for media:

Jacek Zawadzki
jzawadzki@egzogroup.pl
Mobile: +48 694 400 222

Contact for investors:

Jacek Zawadzki
jzawadzki@egzogroup.pl 
Mobile: +48 694 400 222